Upper GI Clinical Trials

Parkview Research Center, in conjunction with Parkview Cancer Institute, continues to search for new cancer treatments. Clinical trials might be an option for you. Talk to your GI care team providers to learn more about any open trials and their eligibility criteria.

Incyte 54828-302

A Phase 3, Open-label, Active-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib vs. Gemcitabine plus Cisplatin Chemotherapy in First-Line Treatment of Particiapants with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Re-arrangement

Learn more.

Axios

A Multicenter, Prospective Study of EUS-Guided Transluminal Gallbladder Drainage in Patients with Acute Cholecystitis as an Alternative to Percutaneous Gallbladder Drainage

Learn more.

Nanopac 2016-05

Phase IIa Trial Evaluating the Safety of Intratumoral Injection of NanoPac ® in Subjects with Locally Advanced Pancreatic Adenocarcinoma

Learn more.

ESD Registry

Multi-center Prospective Evaluation of the Clinical Utility of Endoscopic Submucosal Dissection (ESD) in the Western Population

Learn more.

Cryotherapy and Chemotherapy Quality of life in Esophageal Cancer

Quality of life assessment in patients receiving cryotherapy in addition to chemotherapy for palliation of unresectable esophageal or gastroesophageal cancer

Learn more.

Pancreatic Cancer Collaborative Registry

This clinical trial is studying computer tools for improving early diagnosis and treatment in patients with pancreatic cancer, are at risk for pancreatic cancer, or have a non-cancerous pancreatic disorder.

Learn more.

BESPOKE

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer

Learn more.